EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

RPL6 Interacts with HMGCS1 to Stabilize HIF‐1α by Promoting Cholesterol Production in Hepatocellular Carcinoma

Minli Yang, Shengtao Cheng, Huiying Gu, Shan Zhong, Dapeng Zhang, Xin He, Weixian Chen, Haijun Deng, Jihua Ren, Peng Chen, Ming Tan, Hui Zhang und 4 weitere

Advanced Science · 2025

DOI: 10.1002/advs.202501373 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Science, 2025. Verfasst von Minli Yang und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious Diseases, Key Laboratory of Molecular Biology for Infectious Diseases (Ministry of Education), Institute for Viral Hepatitis…. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Ribosomal Proteins, Liver Neoplasms, Hypoxia-Inducible Factor 1, alpha Subunit. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Chongqing Municipality, Key Technologies Research and Development Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The identification of predictive markers to determine the premetastatic phase before metastasis is critical for developing effective strategies for early detection and prevention. By applying the dynamic network biomarker (DNB) approach to analyze time‐series transcriptomic data from a pulmonary metastasis HCC mouse model, it is revealed that the premetastatic phase occurred during the fourth week after implantation. A total of 142 DNB genes are identified as functionally important biomarkers for HCC metastasis, among which 60S ribosomal protein L6 (RPL6) is a core DNB member. RPL6 is significantly upregulated in HCC tissues with extrahepatic metastasis and is strongly correlated with poor prognosis in HCC patients. RPL6 promotes the invasion and metastasis of HCC cells, both in vitro and in vivo. Mechanistically, RPL6 directly binds to the HMGCS1 mRNA 3′UTR, a rate‐limiting enzyme in cholesterol biosynthesis, thus increasing HMGCS1 mRNA stability and protein expression and subsequently elevating intracellular cholesterol level. Elevated cholesterol inhibits the ubiquitin‐dependent degradation of HIF‐1α, which further results in activation of HIF‐1α signaling pathway. Together, this study provides new insights into the dynamic transcriptome profiles of HCC pulmonary metastasis and establishes an important role for the RPL6‐HMGCS1‐HIF‐1α axis in HCC metastasis, suggesting potential prognostic biomarkers and therapeutic targets in HCC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularRibosomal ProteinsLiver NeoplasmsHypoxia-Inducible Factor 1, alpha SubunitCholesterolHumansMiceAnimalsGene Expression Regulation, NeoplasticCell Line, TumorMaleLung Neoplasms

Stichwörter der Autor:innen

HMGCS1RPL6cholesterolhepatocellular carcinomametastasis

Substanzen

Ribosomal ProteinsHypoxia-Inducible Factor 1, alpha SubunitCholesterolHIF1A protein, human

Autor:innen und Institutionen

  • Department of Infectious Diseases, Key Laboratory of Molecular Biology for Infectious Diseases (Ministry of Education), Institute for Viral Hepatitis, The Second Affiliated Hospital, Chongqing Medical University, Chongq…
  • Department of Clinical Laboratory, Bishan Hospital of Chongqing Medical University, Chongqing, 402760, China.
  • State Key Laboratory of Ultrasound in Medicine and Engineering, College of Biomedical Engineering, Chongqing Medical University, Chongqing, 400016, China.
  • Department of Endocrine and Breast Surgery, The First Affiliated Hospital of Chongqing Medical University, Chongqing, 400016, China.
  • Department of Infectious Disease, Children's Hospital of Chongqing Medical University, National Clinical Research Center for Child Health and Disorders, Ministry of Education Key Laboratory of Child Development and Diso…

ORCID-Profile: Juan Chen

Förderung

  • National Natural Science Foundation of China
  • Natural Science Foundation of Chongqing Municipality
  • Key Technologies Research and Development Program

Zitieren

APA

Yang, M., Cheng, S., Gu, H., Zhong, S., Zhang, D., He, X., Chen, W., Deng, H., Ren, J., Chen, P., Tan, M., Zhang, H., Li, F., Zhang, Z., Hu, Y., & Chen, J. (2025). RPL6 Interacts with HMGCS1 to Stabilize HIF‐1α by Promoting Cholesterol Production in Hepatocellular Carcinoma. Advanced Science. https://doi.org/10.1002/advs.202501373

Vancouver

Yang M, Cheng S, Gu H, Zhong S, Zhang D, He X, et al. RPL6 Interacts with HMGCS1 to Stabilize HIF‐1α by Promoting Cholesterol Production in Hepatocellular Carcinoma. Advanced Science. 2025. doi:10.1002/advs.202501373

BibTeX
@article{Yang2025,
  author = {Yang, Minli and Cheng, Shengtao and Gu, Huiying and Zhong, Shan and Zhang, Dapeng and He, Xin and Chen, Weixian and Deng, Haijun and Ren, Jihua and Chen, Peng and Tan, Ming and Zhang, Hui and Li, Fan and Zhang, Zhenzhen and Hu, Yuan and Chen, Juan},
  title = {RPL6 Interacts with HMGCS1 to Stabilize HIF‐1α by Promoting Cholesterol Production in Hepatocellular Carcinoma},
  journal = {Advanced Science},
  year = {2025},
  doi = {10.1002/advs.202501373}
}
Kostenlos starten →